SPC3649 Multiple Dose Study in Healthy Volunteers

• Status: Completed
• Trial end date: 2010-09-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to investigate the safety and tolerability of SPC3649 given in multiple doses to healthy volunteers.

• Phase: Phase 1
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Santaris Pharma A/S

Criteria

Inclusion Criteria:

• Healthy volunteers: Males and postmenopausal females aged ≥ 18 to 60 years